Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively
The Journal of Immunology (2005) - Comments
pubmed: 16081784  doi: 10.4049/jimmunol.175.4.2174  issn: 0022-1767  issn: 1550-6606 

Mario I. Vega, Ali R. Jazirehi, Sara Huerta-Yepez, Benjamin Bonavida